Skip to content

LYONS GARY A Insider Trading -- Recent SEC Form 4 Transactions

LYONS GARY A (CIK 1123343) reported 18 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-11-19). Recent activity: Sell NBIX (1,200 shares), Sell NBIX (4,011 shares), Sell NBIX (5,689 shares), Sell NBIX (4,100 shares), Buy NBIX (15,000 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-11-19NEUROCRINE BIOSCIENCES INC (NBIX)DirectorSell1,200$195,733
2026-11-19NEUROCRINE BIOSCIENCES INC (NBIX)DirectorSell4,011$657,555
2026-11-19NEUROCRINE BIOSCIENCES INC (NBIX)DirectorSell5,689$939,565
2026-11-19NEUROCRINE BIOSCIENCES INC (NBIX)DirectorSell4,100$680,177
2026-11-19NEUROCRINE BIOSCIENCES INC (NBIX)DirectorBuy15,000$804,600
2026-08-19Travere Therapeutics, Inc. (TVTX)DirectorBuy5,000$87,200
2026-08-19Travere Therapeutics, Inc. (TVTX)DirectorSell1,900$118,807
2026-08-19Travere Therapeutics, Inc. (TVTX)DirectorSell2,600$165,100
2026-08-19Travere Therapeutics, Inc. (TVTX)DirectorSell500$32,080
2026-08-19Travere Therapeutics, Inc. (TVTX)DirectorBuy5,000$87,200
2026-08-19Travere Therapeutics, Inc. (TVTX)DirectorSell4,100$259,407
2026-08-19Travere Therapeutics, Inc. (TVTX)DirectorSell900$57,474
2026-05-21NEUROCRINE BIOSCIENCES INC (NBIX)DirectorBuy1,659$0
2026-05-21Travere Therapeutics, Inc. (TVTX)DirectorBuy4,000$0
2026-04-16Travere Therapeutics, Inc. (TVTX)DirectorBuy8,000$130,640
2026-04-16Travere Therapeutics, Inc. (TVTX)DirectorSell8,000$328,560
2025-12-04NEUROCRINE BIOSCIENCES INC (NBIX)DirectorBuy15,000$718,350
2025-12-04NEUROCRINE BIOSCIENCES INC (NBIX)DirectorSell15,000$2.3M

Source: SEC Form 4 filings · as of 2026-11-19